United States · Platforms & data · MarketBeat

Biogen Q3 Earnings Call Highlights

Published by MarketBeat · United States 1 h ago

Biogen (NASDAQ:BIIB) reported third-quarter 2026 revenue growth of 11% year over year, supported by its acquisition of Apellis and continued expansion of its growth-product…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

The Motley Fool

3 Reasons Why Bitcoin Is Worth Buying Right Now

Seeking Alpha

Universal Display expects full-year revenue toward low end of $630M-$670M range as OLEDX and NovaJet launch

MarketWatch

Biogen Q3 Earnings Call Highlights

Share

Also worth reading

3 Reasons Why Bitcoin Is Worth Buying Right Now

Universal Display expects full-year revenue toward low end of $630M-$670M range as OLEDX and NovaJet launch

ServiceNow’s stock slides as earnings miss overshadows a raised AI outlook

Grove Collaborative at Emerging Growth Conference 97: turnaround gains traction

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Meta, Snap Reportedly Face New US Trial Over Youth Social Media Addiction Claims — Zuckerberg, Spiegel Expected To Testify